WTX-330
WTX-330x2102
Phase 2 small_molecule active
Quick answer
WTX-330 for Advanced or Metastatic Solid Tumors is a Phase 2 program (small_molecule) at Werewolf Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Werewolf Therapeutics
- Indication
- Advanced or Metastatic Solid Tumors
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active